Skip to main content
. 2023 Nov 15;383:e075219. doi: 10.1136/bmj-2023-075219

Fig 2.

Fig 2

Flow of practice sites and participants through study as continuation of figure 1. †Participants remained blinded to treatment arm through all screening processes, until point of consent. CRN=clinical research network; EOI=expression of interest; IPSS=International Prostate Symptom Score